Cugno et al. also found that patients with COVID-19 had high plasma markers of complement activation and endothelial dysfunction, such as soluble C5b-9, C5a, vWF, tissue plasminogen activator (tPA), and PAI-1 [15]. This evidence concerns the gene PLAT and COVID-19.